最新报道:In Denmark's Kalundborg, known as "Novo Town," residents face uncertainty as Novo Nordisk plans to cut about 5,000 jobs locally amid slowing Wegovy sales and a $400 billion share price drop. The company, which became Europe's most valuable last year, is restructuring globally to simplify operations and refocus on diabetes and obesity treatments. Despite the cuts, economists note Novo remains key to Denmark's economy, though growth forecasts have been revised down to 2% for 2025-2027.